EKF Diagnostics, Greenville Health System sales and marketing update

EKF’s subsidiary Selah Genomics launched the PrecisionPath Colon test in the U.S., excluding New York, to determine the best treatment based on the patient’s genetic profile. Selah will extract the DN...